{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:58:56Z","timestamp":1789138736306,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100019679","name":"Manisa Celal Bayar \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00467-026-07334-2","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:44:53Z","timestamp":1778323493000},"page":"3569-3578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urinary podocalyxin identifies a pre-albuminuric kidney injury window and stratifies 12-year diabetic kidney disease risk in youth with type 1 diabetes mellitus"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9146-4809","authenticated-orcid":false,"given":"Seniha Kiremitci","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1696-8406","authenticated-orcid":false,"given":"Betul","family":"Ersoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0239-394X","authenticated-orcid":false,"given":"Nilay Tu\u011f\u00e7e I\u015f\u0131k","family":"Bayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3018-5654","authenticated-orcid":false,"given":"Arzu","family":"Oran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-0460","authenticated-orcid":false,"given":"Fatma","family":"Taneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"1 Suppl 1","key":"7334_CR1","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.2337\/dc25-S011","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 11. Chronic kidney disease and risk management: standards of care in diabetes-2025. Diabetes Care 48(1 Suppl 1):S239\u2013S251. https:\/\/doi.org\/10.2337\/dc25-S011","journal-title":"Diabetes Care"},{"key":"7334_CR2","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, Rosas SE, Rossing P, Bakris G (2022) Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care 45:3075\u20133090. https:\/\/doi.org\/10.2337\/dci22-0027","journal-title":"Diabetes Care"},{"key":"7334_CR3","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s00467-021-05347-7","volume":"37","author":"LN Lopez","year":"2022","unstructured":"Lopez LN, Wang W, Loomba L, Afkarian M, Butani L (2022) Diabetic kidney disease in children and adolescents: an update. Pediatr Nephrol 37:2583\u20132597. https:\/\/doi.org\/10.1007\/s00467-021-05347-7","journal-title":"Pediatr Nephrol"},{"key":"7334_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s001250051151","volume":"42","author":"CE Mogensen","year":"1999","unstructured":"Mogensen CE (1999) Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 42:263\u2013285. https:\/\/doi.org\/10.1007\/s001250051151","journal-title":"Diabetologia"},{"key":"7334_CR5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","volume":"20","author":"RJ Macisaac","year":"2011","unstructured":"Macisaac RJ, Jerums G (2011) Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens 20:246\u2013257. https:\/\/doi.org\/10.1097\/MNH.0b013e3283456546","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"7334_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s10157-017-1485-7","volume":"22","author":"K Furuichi","year":"2018","unstructured":"Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hohino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Makino H, Matsuo S, Wada T (2018) Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy. Clin Exp Nephrol 22:570\u2013582. https:\/\/doi.org\/10.1007\/s10157-017-1485-7","journal-title":"Clin Exp Nephrol"},{"key":"7334_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2337\/diabetes.52.4.1036","volume":"52","author":"ML Caramori","year":"2003","unstructured":"Caramori ML, Fioretto P, Mauer M (2003) Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 52:1036\u20131040. https:\/\/doi.org\/10.2337\/diabetes.52.4.1036","journal-title":"Diabetes"},{"key":"7334_CR8","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.2337\/diabetes.54.7.2164","volume":"54","author":"JM Steinke","year":"2005","unstructured":"Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M (2005) The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54:2164\u20132171. https:\/\/doi.org\/10.2337\/diabetes.54.7.2164","journal-title":"Diabetes"},{"key":"7334_CR9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/archinternmed.2011.16","volume":"171","author":"IH de Boer","year":"2011","unstructured":"de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM (2011) Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171:412\u2013420. https:\/\/doi.org\/10.1001\/archinternmed.2011.16","journal-title":"Arch Intern Med"},{"key":"7334_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2478\/jomb-2019-0026","volume":"39","author":"I Kostovska","year":"2020","unstructured":"Kostovska I, Tosheska-Trajkovska K, Topuzovska S, Cekovska S, Spasovski G, Kostovski O, Labudovic D (2020) Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria. J Med Biochem 39:83\u201390. https:\/\/doi.org\/10.2478\/jomb-2019-0026","journal-title":"J Med Biochem"},{"key":"7334_CR11","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.2337\/diabetes.52.12.2969","volume":"52","author":"A P\u00e4t\u00e4ri","year":"2003","unstructured":"P\u00e4t\u00e4ri A, Forsblom C, Havana M, Taipale H, Groop PH, Holth\u00f6fer H (2003) Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 52:2969\u20132974. https:\/\/doi.org\/10.2337\/diabetes.52.12.2969","journal-title":"Diabetes"},{"key":"7334_CR12","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s00125-012-2661-7","volume":"55","author":"M Hara","year":"2012","unstructured":"Hara M, Yamagata K, Tomino Y, Saito A, Hirayama Y, Ogasawara S, Kurosawa H, Sekine S, Yan K (2012) Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia 55:2913\u20132919. https:\/\/doi.org\/10.1007\/s00125-012-2661-7","journal-title":"Diabetologia"},{"key":"7334_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.nefroe.2022.11.007","volume":"42","author":"Y Xie","year":"2022","unstructured":"Xie Y, Jin D, Qiu H, Lin L, Sun S, Li D, Sha F, Zhou W, Jia M (2022) Assessment of urinary podocalyxin as an alternative marker for urinary albumin creatinine ratio in early stage of diabetic kidney disease in older patients. Nefrologia 42:664\u2013670. https:\/\/doi.org\/10.1016\/j.nefroe.2022.11.007","journal-title":"Nefrologia"},{"key":"7334_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4647685","volume":"2016","author":"T Fiseha","year":"2016","unstructured":"Fiseha T, Tamir Z (2016) Urinary markers of tubular injury in early diabetic nephropathy. Int J Nephrol 2016:4647685. https:\/\/doi.org\/10.1155\/2016\/4647685","journal-title":"Int J Nephrol"},{"key":"7334_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/IJNRD.S143186","volume":"10","author":"SN Uwaezuoke","year":"2017","unstructured":"Uwaezuoke SN (2017) The role of novel biomarkers in predicting diabetic nephropathy: a review. Int J Nephrol Renovasc Dis 10:221\u2013231. https:\/\/doi.org\/10.2147\/IJNRD.S143186","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"7334_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112292","volume":"226","author":"ZA Wani","year":"2025","unstructured":"Wani ZA, Ahmed S, Saleh A, Anna VR, Fahelelbom KM, Raju SK, Abu-Rayyan A, Bhat AR (2025) Biomarkers in diabetic nephropathy: a comprehensive review of their role in early detection and disease progression monitoring. Diabetes Res Clin Pract 226:112292. https:\/\/doi.org\/10.1016\/j.diabres.2025.112292","journal-title":"Diabetes Res Clin Pract"},{"key":"7334_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10157-024-02465-y","volume":"28","author":"A Fukuda","year":"2024","unstructured":"Fukuda A, Sato Y, Shibata H, Fujimoto S, Wiggins RC (2024) Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases. Clin Exp Nephrol 28:496\u2013504. https:\/\/doi.org\/10.1007\/s10157-024-02465-y","journal-title":"Clin Exp Nephrol"},{"key":"7334_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2337\/db16-0796","volume":"66","author":"RE Gilbert","year":"2017","unstructured":"Gilbert RE (2017) Proximal tubulopathy: Prime mover and key therapeutic target in diabetic kidney disease. Diabetes 66:791\u2013800. https:\/\/doi.org\/10.2337\/db16-0796","journal-title":"Diabetes"},{"key":"7334_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155195","volume":"131","author":"L Yao","year":"2022","unstructured":"Yao L, Liang X, Qiao Y, Chen B, Wang P, Liu Z (2022) Mitochondrial dysfunction in diabetic tubulopathy. Metabolism 131:155195. https:\/\/doi.org\/10.1016\/j.metabol.2022.155195","journal-title":"Metabolism"},{"key":"7334_CR20","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s13300-025-01731-w","volume":"16","author":"E Satta","year":"2025","unstructured":"Satta E, Strollo F, Borgia L, Guarino G, Romano C, Masarone M, Marfella R, Gentile S (2025) Urinary L-FABP: A novel biomarker for evaluating diabetic nephropathy onset and progression. A narrative review. Diabetes Ther 16:1107\u20131124. https:\/\/doi.org\/10.1007\/s13300-025-01731-w","journal-title":"Diabetes Ther"},{"key":"7334_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11892-015-0633-2","volume":"15","author":"P Bjornstad","year":"2015","unstructured":"Bjornstad P, Cherney DZ, Maahs DM (2015) Update on estimation of kidney function in diabetic kidney disease. Curr Diab Rep 15:57. https:\/\/doi.org\/10.1007\/s11892-015-0633-2","journal-title":"Curr Diab Rep"},{"key":"7334_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.914587","volume":"9","author":"L Zhang","year":"2022","unstructured":"Zhang L, Xue S, Wu M, Dong D (2022) Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis. Front Med (Lausanne) 9:914587. https:\/\/doi.org\/10.3389\/fmed.2022.914587","journal-title":"Front Med (Lausanne)"},{"key":"7334_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75320-1","volume":"10","author":"A Fukuda","year":"2020","unstructured":"Fukuda A, Minakawa A, Kikuchi M, Sato Y, Nagatomo M, Nakamura S, Mizoguchi T, Fukunaga N, Shibata H, Naik AS, Wiggins RC, Fujimoto S (2020) Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy. Sci Rep 10:18209. https:\/\/doi.org\/10.1038\/s41598-020-75320-1","journal-title":"Sci Rep"},{"key":"7334_CR24","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.2337\/dc09-0429","volume":"32","author":"SE Nielsen","year":"2009","unstructured":"Nielsen SE, Sugaya T, Tarnow L, Lajer M, Schjoedt KJ, Astrup AS, Baba T, Parving HH, Rossing P (2009) Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care 32:1684\u20131688. https:\/\/doi.org\/10.2337\/dc09-0429","journal-title":"Diabetes Care"},{"key":"7334_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036041","volume":"7","author":"B Jim","year":"2012","unstructured":"Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, Abadi M, Thomas DB, He JC (2012) Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One 7:e36041. https:\/\/doi.org\/10.1371\/journal.pone.0036041","journal-title":"PLoS One"},{"key":"7334_CR26","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2337\/dc18-1320","volume":"42","author":"M Yamanouchi","year":"2019","unstructured":"Yamanouchi M, Furuichi K, Hoshino J, Toyama T, Hara A, Shimizu M, Kinowaki K, Fujii T, Ohashi K, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Mise K, Makino H, Matsuo S, Ubara Y, Wada T (2019) Nonproteinuric versus proteinuric phenotypes in diabetic kidney disease: a propensity score-matched analysis of a nationwide, biopsy-based cohort study. Diabetes Care 42:891\u2013902. https:\/\/doi.org\/10.2337\/dc18-1320","journal-title":"Diabetes Care"},{"key":"7334_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.2337\/dc15-0184","volume":"38","author":"AS Krolewski","year":"2015","unstructured":"Krolewski AS (2015) Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care 38:954\u2013962. https:\/\/doi.org\/10.2337\/dc15-0184","journal-title":"Diabetes Care"},{"key":"7334_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.1020443","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu H, Feng J, Tang L (2022) Early renal structural changes and potential biomarkers in diabetic nephropathy. Front Physiol 13:1020443. https:\/\/doi.org\/10.3389\/fphys.2022.1020443","journal-title":"Front Physiol"},{"key":"7334_CR29","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12:2032\u20132045. https:\/\/doi.org\/10.2215\/cjn.11491116","journal-title":"Clin J Am Soc Nephrol"},{"key":"7334_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.832887","volume":"10","author":"S Liu","year":"2022","unstructured":"Liu S, Yuan Y, Xue Y, Xing C, Zhang B (2022) Podocyte injury in diabetic kidney disease: a focus on mitochondrial dysfunction. Front Cell Dev Biol 10:832887. https:\/\/doi.org\/10.3389\/fcell.2022.832887","journal-title":"Front Cell Dev Biol"},{"key":"7334_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1064665","volume":"13","author":"Z Gao","year":"2022","unstructured":"Gao Z, Zhu Y, Sun X, Zhu H, Jiang W, Sun M, Wang J, Liu L, Zheng H, Qin Y, Zhang S, Yang Y, Xu J, Yang J, Shan C, Chang B (2022) Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: a multi-center, prospective cohort study. Front Endocrinol (Lausanne) 13:1064665. https:\/\/doi.org\/10.3389\/fendo.2022.1064665","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7334_CR32","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2337\/dc18-1125","volume":"41","author":"ML Marcovecchio","year":"2018","unstructured":"Marcovecchio ML, Chiesa ST, Armitage J, Daneman D, Donaghue KC, Jones TW, Mahmud FH, Marshall SM, Neil HAW, Dalton RN, Deanfield J, Dunger DB (2018) Renal and cardiovascular risk according to tertiles of urinary albumin-to-creatinine ratio: the Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT). Diabetes Care 41:1963\u20131969. https:\/\/doi.org\/10.2337\/dc18-1125","journal-title":"Diabetes Care"},{"key":"7334_CR33","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"KDIGO","year":"2024","unstructured":"KDIGO (2024) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 105:S117-s314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"7334_CR34","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.7860\/jcdr\/2013\/6589.3768","volume":"7","author":"M Pathania","year":"2013","unstructured":"Pathania M, Rathaur VK, Yadav N, Jayara A, Chaturvedi A (2013) Quantitative micro-albuminuria assessment from \u2018random voided urinary albumin: creatinine ratio\u2019 versus \u201824 hours urinary albumin concentration\u2019 for screening of diabetic nephropathy. J Clin Diagn Res 7:2828\u20132831. https:\/\/doi.org\/10.7860\/jcdr\/2013\/6589.3768","journal-title":"J Clin Diagn Res"},{"key":"7334_CR35","first-page":"798","volume":"14","author":"KF Yassin","year":"2025","unstructured":"Yassin KF, Zbaar AS (2025) Assessment the level of urinary podocalyxin as an early biomarker in diabetic nephropathy. J Neonatal Surg 14:798\u2013804","journal-title":"J Neonatal Surg"},{"key":"7334_CR36","doi-asserted-by":"publisher","first-page":"F589","DOI":"10.1152\/ajprenal.00368.2001","volume":"283","author":"PH Lane","year":"2002","unstructured":"Lane PH (2002) Diabetic kidney disease: impact of puberty. Am J Physiol Renal Physiol 283:F589\u2013F600. https:\/\/doi.org\/10.1152\/ajprenal.00368.2001","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07334-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07334-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07334-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:47:49Z","timestamp":1786978069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07334-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["7334"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07334-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}